Cargando…
MLL4 mediates differentiation and tumor suppression through ferroptosis
The epigenetic regulator, MLL4 (KMT2D), has been described as an essential gene in both humans and mice. In addition, it is one of the most commonly mutated genes in all of cancer biology. Here, we identify a critical role for Mll4 in the promotion of epidermal differentiation and ferroptosis, a key...
Autores principales: | Egolf, Shaun, Zou, Jonathan, Anderson, Amy, Simpson, Cory L., Aubert, Yann, Prouty, Stephen, Ge, Kai, Seykora, John T., Capell, Brian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664260/ https://www.ncbi.nlm.nih.gov/pubmed/34890228 http://dx.doi.org/10.1126/sciadv.abj9141 |
Ejemplares similares
-
CARM1-mediated methylation of ASXL2 impairs tumor-suppressive function of MLL3/COMPASS
por: Zhao, Zibo, et al.
Publicado: (2022) -
RNA binding induces an allosteric switch in Cyp33 to repress MLL1-mediated transcription
por: Blatter, Markus, et al.
Publicado: (2023) -
LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors
por: Egolf, Shaun, et al.
Publicado: (2019) -
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction
por: Fujihara, Kenji M., et al.
Publicado: (2022) -
A nonferrous ferroptosis-like strategy for antioxidant inhibition–synergized nanocatalytic tumor therapeutics
por: Wu, Chenyao, et al.
Publicado: (2021)